ClinicalTrials.gov
ClinicalTrials.gov Menu

Infections in Pediatric Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00930267
Recruitment Status : Unknown
Verified June 2009 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : June 30, 2009
Last Update Posted : June 30, 2009
Sponsor:
Information provided by:
Hadassah Medical Organization

Brief Summary:

A prospective epidemiological study conducted in pediatric hematology oncology center in Hadassah medical center. The study will include all newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during chemotherapy.

In each event of febrile episode during chemotherapy, the following data will be collected using a patient data form and computerized software.

Demographic data: age, gender, ethnicity. Clinical data: Underlying disease, immunizations, prophylactic antibiotics, presence of central venous catheter, intensity of chemotherapy, duration of fever, duration and severity of neutropenia, diagnosis of present event.

Imaging data Microbiological data Outcome The statistical analysis will be performed by an epidemiologist and statistician using the SPSS 12.0 software.


Condition or disease
Infections

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Epidemiology and Etiology of Infections in Pediatric Cancer Patients: A Prospective Study




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy
Criteria

Inclusion Criteria:

  • Pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy

Exclusion Criteria:

  • No exclusions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00930267


Contacts
Contact: Arik Tzukert, DMD 00 972 2 6776095 arik@hadassah.org.il
Contact: Hadas Lemberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il

Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Dan Engelhard, MD Hadassah Medical Center
Principal Investigator: Diana Averbuch, MD Hadassah Medical Center

ClinicalTrials.gov Identifier: NCT00930267     History of Changes
Other Study ID Numbers: yael12-HMO-CTIL
First Posted: June 30, 2009    Key Record Dates
Last Update Posted: June 30, 2009
Last Verified: June 2009

Keywords provided by Hadassah Medical Organization:
fever
children
cancer
leukemia
stem cell transplantation
infections in pediatric cancer patients presenting with fever during or following chemotherapy.

Additional relevant MeSH terms:
Infection
Communicable Diseases